Search results for "Metronidazol"

showing 10 items of 46 documents

“AD HOC” MODIFIED CLAYS FOR BIOTECHNOLOGICAL APPLICATIONS

Nowadays, the scientific community has to face with cogent problems strictly linked to the improvement of quality of live. Among the different tasks to achieve the prefixed objective the focus has been put on the drug administration, i.e., attention has been paid to propose an appropriate solution to improve the performance of a drug delivery system and to eliminate both the side effect and drawbacks. With the aim to achieve the design, synthesis, and characterization of versatile systems, with peculiar characteristics, based on clays and clays modified with a biocompatible surfactant, able to adsorb and release organic substances of pharmaceutical interest the present PhD thesis has been u…

Clays drug delivery systems montmorillonite caolinite sepiolite organoclays tween 20 metronidazole Vitamin A Cinnamic Acid Nile RedArgille sistemi a rilascio modificato del farmaco montmorillonite caoinite sepiolite organoargille tween 20 metrinidazolo Vitamina A acido cinnamico Nile redSettore CHIM/02 - Chimica Fisica
researchProduct

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.

2017

Background and aims Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis is administered. Evidence for optimal treatment is lacking. Our aim was to compare the efficacy of adalimumab [ADA] and azathioprine [AZA] in this setting. Methods We performed a phase 3, 52-week, multicentre, randomised, superiority study [APPRECIA], in which patients with ileocolonic resection were randomised either to ADA 160-80-40 mg subcutaneously [SC] or AZA 2.5 mg/kg/day, both associated with metronidazole. The primary endpoint was endoscopic recurrence at 1 year [Rutgeerts i2b, i3, i4], as evaluated by a blinded central reader. Results We recruited 91 patients [median age 35.…

Crohn’s diseaseAdultMalemedicine.medical_specialtyAzathioprineGastroenterology03 medical and health sciences0302 clinical medicineCrohn DiseaseInternal medicineadalimumabAzathioprinemedicineClinical endpointAdalimumabSecondary PreventionHumansAdverse effectPostoperative CareCrohn's diseaseazathioprinebusiness.industryAdalimumabGastroenterologyGeneral Medicinemedicine.diseaseSurgeryDiscontinuationCrohn's diseaseMetronidazole030220 oncology & carcinogenesisUnselected population030211 gastroenterology & hepatologyFemalebusinessImmunosuppressive Agentsmedicine.drug
researchProduct

Modified Montmorillonite as Drug Delivery Agent for Enhancing Antibiotic Therapy

2021

The appealing properties of surfactant-intercalated Montmorillonites (Organo-montmorillonite, OMt) were successfully investigated to propose an effective drug delivery system for metronidazole (MNE) antibiotic therapy. This represents a serious pharmaceutical concern due to the adverse drug reactions and the low targeting ability of MNE. The non-ionic surfactant Tween 20 was used to functionalize montmorillonite, thus accomplishing the two-fold objective of enhancing the stability of clay dispersion and better controlling drug uptake and release. The adsorption process was performed under different experimental conditions and investigated by constructing the adsorption isotherms through hig…

DrugBiocompatibilitymedia_common.quotation_subjectmontmorillonite; organoclay; metronidazole; surfactant; adsorption; release; drug delivery systemDrug delivery systemGeologyMineralogyGeotechnical Engineering and Engineering GeologyControlled releasechemistry.chemical_compoundMontmorilloniteAdsorptionchemistryPulmonary surfactantChemical engineeringMetronidazoleReleaseSurfactantDrug deliveryOrganoclayAdsorptionOrganoclayQE351-399.2Montmorillonitemedia_commonMinerals; Volume 11; Issue 12; Pages: 1315
researchProduct

Montmorillonite nanodevices for the colon metronidazole delivery.

2013

The adsorption profiles of the antibiotic metronidazole (MNE) into the K10-montmorillonite (MMT-K10) clay and the subsequent release have been investigated as a function of pH and MNE/MMT-K10 ratio, in order to evaluate the potential of the MNE/MMT-K10 hybrids as controlled drug delivery system. The adsorption mechanism has been first elucidated by performing complementary equilibrium and kinetic studies and through the X-ray diffractometry (XRD) characterization of the obtained composite materials. The gathered results allowed us to propose a mechanism consisting of a multi-step pathway involving the neutral and the cationic form of the drug, which interact with different sites of the clay…

DrugColonmedia_common.quotation_subjectPharmaceutical ScienceDrug release kineticschemistry.chemical_compoundAdsorptionDrug Delivery SystemsMetronidazolemedicineOrganic chemistrymedia_commonSettore CHIM/02 - Chimica FisicaK10-montmorillonite metronidazole adsorption drug deliverySettore GEO/06 - MineralogiaCationic polymerizationAnti-Bacterial AgentsNanostructuresMetronidazoleMontmorillonitechemistryChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryBentoniteOral retinoidmedicine.drugInternational journal of pharmaceutics
researchProduct

A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis

2021

Background Gingivitis is one of the most prevalent oral disease in humans. The most important etiological factor of gingivitis is dental plaque. Plaque control procedures comprises of several mechanical and chemical methods. Many studies have advocated that chemical plaque control methods can be used successfully as an adjunct to mechanical plaque control procedures. Thus, the aim of this pilot study is to evaluate the effectiveness of two topical antimicrobial gels as an adjunct to mechanical plaque control over a period of 2 weeks in treatment of chronic gingivitis patients. Material and methods This is a single blind, two arm parallel design pilot clinical study including 60 systemically…

Generalized gingivitisbusiness.industryResearchDentistryAntimicrobialDental plaquemedicine.diseaseGingivitisMetronidazoleScaling and root planingClinical attachment lossMedicinePeriodontologymedicine.symptombusinessGeneral DentistryChronic gingivitisUNESCO:CIENCIAS MÉDICASmedicine.drug
researchProduct

No association between Helicobacter pylori genotypes and antibiotic resistance phenotypes within families.

2002

Background. Triple therapy combining a proton pump inhibitor with two antibiotics, e.g. clarythromycin (CLR), metronidazole (MTZ) or amoxicillin (AMX), represents the standard in Helicobacter pylori eradication regimens. Resistance to antimicrobial agents, particularly MTZ (up to 56% in Western countries) and CLR (up to 15% in southern Europe), is frequently observed and may be associated with treatment failure [1]. Recently, several studies indicated that individual H. pylori colonies from a single anatomic site may not always yield identical genotypes, or the identical patterns of susceptibility to antibiotics [2–5]. Representative for every single patient we analyzed 27 H. pylori antrum …

Genotypemedicine.drug_classAntibioticsDrug resistanceMicrobial Sensitivity TestsPolymerase Chain ReactionMicrobiologyHelicobacter InfectionsAntibiotic resistanceDrug Resistance BacterialmedicineHelicobacterbiologyHelicobacter pyloriGastroenterologyGeneral MedicineAmoxicillinHelicobacter pyloribiology.organism_classificationAntimicrobialAnti-Bacterial AgentsElectrophoresis Gel Pulsed-FieldMetronidazoleInfectious DiseasesPhenotypePolymorphism Restriction Fragment Lengthmedicine.drugHelicobacter
researchProduct

Secretin—cerulein test and fecal chymotrypsin concentration in children with intestinal giardiasis

1993

We studied six patients with giardiasis (five males, one female), median age 3.5 yr (range 1-11) and 12 healthy control subjects (10 males, 2 females), median age 3.5 yr (range 1-10). Intestinal biopsy and a contemporaneous secretin-cerulein test were performed in all patients, and fecal chymotrypsin was also assayed. Intestinal biopsy was normal in five of the six patients with giardiasis, whereas one of the six presented a partial atrophy of the intestinal villi. The secretin-cerulein test (1 CU/kg of secretin + 75 ng/kg of cerulein) did not show any significant difference between values in the outputs of chymotrypsin, lipase, phospholipase, and bicarbonate obtained in patients and in con…

GiardiasisMalemedicine.medical_specialtyBicarbonatemedicine.disease_causeGastroenterologySecretinFeceschemistry.chemical_compoundEndocrinologyPancreatic JuiceSecretinInternal medicinemedicineChymotrypsinHumansGiardia lambliaLipaseChildPancreasFecesFecal chymotrypsinChymotrypsinbiologyGastroenterologyInfantMetronidazoleEndocrinologyOncologychemistryChild Preschoolbiology.proteinFemaleCeruletidemedicine.drugInternational journal of pancreatology
researchProduct

Secondary impairment of pancreatic function as a cause of severe malabsorption in intestinal giardiasis: A case report

1997

We report the case of a 54-year-old male patient hospitalized for diarrhea and weight loss (8 kg over the previous three months). At admission, we observed pale oral and conjunctival mucosa and peripheral edema of the lower limbs. Stool frequency was 8-10 per day. Laboratory data were as follows: hemoglobin, 11 g/dL; total proteins, 4.3 g/dL; albumin, 2 g/dL; pseudocholinesterase, 1248 U/L; triglycerides, 54 mg/dL; serum cholesterol, 102 mg/dL; calcium, 7.9 mg/dL. Fecal fat was 8.2 g/24 hr. Fecal chymotrypsin (FCT) was 2.3 U/g. A duodenal probe was performed after administration of intravenous secretin and cerulein stimulation, and a contemporaneous mucosal biopsy was taken at the ligament …

GiardiasisMalemedicine.medical_specialtyPancreatic diseaseMalabsorptionPeripheral edemaAntiprotozoal AgentsAntitrichomonal AgentsGastroenterologyAsymptomaticMalabsorption SyndromesVirologyInternal medicineMetronidazolemedicineAnimalsHumansbusiness.industryAlbuminMiddle Agedmedicine.diseaseSteatorrheaDiarrheaMetronidazoleInfectious DiseasesEndocrinologyParasitologyExocrine Pancreatic Insufficiencymedicine.symptomGiardia lambliabusinessmedicine.drug
researchProduct

NEW GUIDED BONE REGENERATION PROCEDURE USING LEUKOCYTE AND PLATELET RICH FIBRIN (L PRF) IN ORAL SURGERY

2021

Non-transfusional hemocomponents are autogenous products used in several surgical fields obtained by the centrifugation of a blood sample from a patient and able to promote hard and soft tissue regeneration, local haemostasis, and the acceleration of wound healing. The aim of this PhD thesis was the validation of an innovative protocol for the Guided Bone Regeneration (GBR) technique using second-generation autologous platelet concentrates, Leukocytes and Platelet-rich Fibrin (L-PRF), in post-extraction sockets of patients in need of dental avulsions and successive implant prosthetic rehabilitation, evaluating its ability to prevent alveolar bone resorption and promote bone regeneration. Th…

Guided Bone Regenerationtooth extractionmetronidazolenanocompositeSettore MED/28 - Malattie OdontostomatologicheSettore CHIM/09 - Farmaceutico Tecnologico Applicativohyaluronic acid.platelet-rich fibrinL-PRFcurcuminnon-transfusional hemocomponentnanostructured lipid carrierhydrophilic sponge
researchProduct

Bioadhesive Matrix Tablets Loaded with Lipophilic Nanoparticles as Vehicles for Drugs for Periodontitis Treatment: Development and Characterization

2019

Periodontitis treatment is usually focused on the reduction or eradication of periodontal pathogens using antibiotics against anaerobic bacteria, such as metronidazole (MTR). Moreover, recently the correlation between periodontal diseases and overexpression of reactive oxygen species (ROS) led to the introduction of antioxidant biomolecules in therapy. In this work, bioadhesive buccal tablets, consisting of a hydrophilic matrix loaded with metronidazole and lipophilic nanoparticles as a vehicle of curcumin, were developed. Curcumin (CUR)-loaded nanostructured lipid carriers (NLC) were prepared using glycyrrhetic acid, hexadecanol, isopropyl palmitate and Tween&reg

Isopropyl palmitateoral mucosal drug deliveryPolymers and PlasticsBioadhesiveSonicationbuccal matrix tabletsnanostructured lipid carriersbuccal matrix tablet02 engineering and technologynanostructured lipid carrier030226 pharmacology & pharmacyhydrophilic spongeArticlelcsh:QD241-44103 medical and health scienceschemistry.chemical_compound0302 clinical medicinemetronidazolelcsh:Organic chemistryPulmonary surfactantMucoadhesioncurcuminoral diseaseperiodontitisChromatographyChemistryGeneral ChemistryBuccal administrationPermeation021001 nanoscience & nanotechnologySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNLCAnaerobic bacteria0210 nano-technologybuccal delivery
researchProduct